BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1014 related articles for article (PubMed ID: 22393786)

  • 1. [Nuclear beta-catenin localization is not sufficient for canonical Wnt signaling activation in human meianoma cell lines].
    Kulikova KV; Posviatenko AV; Gnuchev NV; Georgiev GP; Kibardin AV; Larin SS
    Mol Biol (Mosk); 2011; 45(5):884-91. PubMed ID: 22393786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K; Akcali KC; Ozturk M
    Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential.
    Murakami T; Toda S; Fujimoto M; Ohtsuki M; Byers HR; Etoh T; Nakagawa H
    Biochem Biophys Res Commun; 2001 Oct; 288(1):8-15. PubMed ID: 11594745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.
    Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ
    Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C ζ is a positive modulator of canonical Wnt signaling pathway in tumoral colon cell lines.
    Luna-Ulloa LB; Hernández-Maqueda JG; Santoyo-Ramos P; Castañeda-Patlán MC; Robles-Flores M
    Carcinogenesis; 2011 Nov; 32(11):1615-24. PubMed ID: 21859831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant activation of Wnt pathway and loss of mismatch repair function in human melanoma.
    Castiglia D; Bernardini S; Alvino E; Pagani E; De Luca N; Falcinelli S; Pacchiarotti A; Bonmassar E; Zambruno G; D'Atri S
    Genes Chromosomes Cancer; 2008 Jul; 47(7):614-24. PubMed ID: 18384130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of the Wnt/beta-catenin signaling pathway in canine cutaneous melanotic tumor.
    Han JI; Kim DY; Na KJ
    Vet Pathol; 2010 Mar; 47(2):285-91. PubMed ID: 20139375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of β-catenin results in lack of β-catenin signaling in melanoma.
    Kuphal S; Bosserhoff AK
    Int J Oncol; 2011 Jul; 39(1):235-43. PubMed ID: 21584489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt3a stimulates Mepe, matrix extracellular phosphoglycoprotein, expression directly by the activation of the canonical Wnt signaling pathway and indirectly through the stimulation of autocrine Bmp-2 expression.
    Cho YD; Kim WJ; Yoon WJ; Woo KM; Baek JH; Lee G; Kim GS; Ryoo HM
    J Cell Physiol; 2012 Jun; 227(6):2287-96. PubMed ID: 22213482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear translocations of beta-catenin and TCF4 in gastric cancers correlate with lymph node metastasis but probably not with CD44 expression.
    Chen XY; Wang ZC; Li H; Cheng XX; Sun Y; Wang XW; Wu ML; Liu J
    Hum Pathol; 2005 Dec; 36(12):1294-301. PubMed ID: 16311123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-Catenin mutation and its nuclear localization are confirmed to be frequent causes of Wnt signaling pathway activation in pilomatricomas.
    Xia J; Urabe K; Moroi Y; Koga T; Duan H; Li Y; Furue M
    J Dermatol Sci; 2006 Jan; 41(1):67-75. PubMed ID: 16378715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway.
    Flahaut M; Meier R; Coulon A; Nardou KA; Niggli FK; Martinet D; Beckmann JS; Joseph JM; Mühlethaler-Mottet A; Gross N
    Oncogene; 2009 Jun; 28(23):2245-56. PubMed ID: 19421142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.
    Kang DW; Lee SH; Yoon JW; Park WS; Choi KY; Min do S
    Cancer Res; 2010 May; 70(10):4233-42. PubMed ID: 20442281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyethylenimine-cationized beta-catenin protein transduction activates the Wnt canonical signaling pathway more effectively than cationic lipid-based transduction.
    Kitazoe M; Futami J; Nishikawa M; Yamada H; Maeda Y
    Biotechnol J; 2010 Apr; 5(4):385-92. PubMed ID: 20235145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune suppression and resistance mediated by constitutive activation of Wnt/β-catenin signaling in human melanoma cells.
    Yaguchi T; Goto Y; Kido K; Mochimaru H; Sakurai T; Tsukamoto N; Kudo-Saito C; Fujita T; Sumimoto H; Kawakami Y
    J Immunol; 2012 Sep; 189(5):2110-7. PubMed ID: 22815287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LRP8 mediates Wnt/β-catenin signaling and controls osteoblast differentiation.
    Zhang J; Zhang X; Zhang L; Zhou F; van Dinther M; Ten Dijke P
    J Bone Miner Res; 2012 Oct; 27(10):2065-74. PubMed ID: 22589174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the canonical WNT signaling pathway promotes ovarian surface epithelial proliferation without inducing β-catenin/Tcf-mediated reporter expression.
    Usongo M; Li X; Farookhi R
    Dev Dyn; 2013 Mar; 242(3):291-300. PubMed ID: 23239518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt/β-catenin signaling mediates the antitumor activity of magnolol in colorectal cancer cells.
    Kang YJ; Park HJ; Chung HJ; Min HY; Park EJ; Lee MA; Shin Y; Lee SK
    Mol Pharmacol; 2012 Aug; 82(2):168-77. PubMed ID: 22550094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer.
    Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro RNA interference against beta-catenin inhibits the proliferation of pediatric hepatic tumors.
    Sangkhathat S; Kusafuka T; Miao J; Yoneda A; Nara K; Yamamoto S; Kaneda Y; Fukuzawa M
    Int J Oncol; 2006 Mar; 28(3):715-22. PubMed ID: 16465377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.